U.S. markets close in 1 hour 19 minutes
  • S&P 500

    3,842.14
    -28.15 (-0.73%)
     
  • Dow 30

    31,456.27
    +64.75 (+0.21%)
     
  • Nasdaq

    13,062.37
    -296.42 (-2.22%)
     
  • Russell 2000

    2,218.35
    -13.16 (-0.59%)
     
  • Crude Oil

    61.38
    +1.63 (+2.73%)
     
  • Gold

    1,711.30
    -22.30 (-1.29%)
     
  • Silver

    26.22
    -0.66 (-2.45%)
     
  • EUR/USD

    1.2073
    -0.0015 (-0.12%)
     
  • 10-Yr Bond

    1.4690
    +0.0540 (+3.82%)
     
  • GBP/USD

    1.3961
    +0.0005 (+0.03%)
     
  • USD/JPY

    106.9600
    +0.2500 (+0.23%)
     
  • BTC-USD

    50,600.01
    +2,750.86 (+5.75%)
     
  • CMC Crypto 200

    1,013.43
    +25.33 (+2.56%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Company News for Apr 1, 2020

Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of Kiniksa Pharmaceuticals, Ltd. KNSA surged 26.7% after the company reported “early evidence of treatment response” with mavrilimumab in six patients suffering from severe coronavirus pneumonia and hyper-inflammation.

  • Shares of EyeGate Pharmaceuticals, Inc. EYEG gained 27.8% after the clinical-stage specialty pharmaceutical company announced topline data in follow-on dry eye pilot study.

  • Shares of VBI Vaccines Inc. VBIV gained1.1% after the company announced collaboration with the National Research Council of Canada to develop a pan-coronavirus vaccine candidate that targeted Coronavirus, SARS and MERS.

  • Shares of Second Sight Medical Products, Inc. EYES fell12.8% after the company announced plans to lay off about 84 of its 108 employees effective Mar 31.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Second Sight Medical Products, Inc. (EYES) : Free Stock Analysis Report
 
VBI Vaccines, Inc. (VBIV) : Free Stock Analysis Report
 
Kiniksa Pharmaceuticals, Ltd. (KNSA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research